Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.

CONCLUSIONS: Empagliflozin reduced BP and had favourable effects on markers of arterial stiffness and vascular resistance.
PMID: 26343814 [PubMed - as supplied by publisher]

Source: Diabetes Metab - September 7, 2015 Category: Endocrinology Authors: Chilton R, Tikkanen I, Cannon CP, Crowe S, Woerle HJ, Broedl UC, Johansen OE Tags: Diabetes Obes Metab Source Type: research